Global CRO Worldwide Clinical Trials will acquire Catalyst Clinical Research, which has particular expertise in oncology. Worldwide is a portfolio company of Kohlberg, a private equity firm. Read more in MedCity News here.
| In The News
Worldwide Clinical Trials to Buy Catalyst
Recent In The News
Resources
Our extensive collection of scientific articles and papers